https://quibim.ai/cases/early-detection-of-localized-colon-cancer-relapse-using-an-ai-based-predictive-model/ 2023-09-26T12:56:14+00:00 https://quibim.ai/wp-content/uploads/2022/12/early_detection_small.jpg https://quibim.ai/cases/managing-storing-and-analyzing-imaging-and-multi-omics-data-through-qp-insights-platform/ 2024-10-22T15:01:06+00:00 https://quibim.ai/wp-content/uploads/2022/12/coverplatform.jpg https://quibim.ai/cases/prognostic-value-of-genetic-alterations-and-18f-fdg-pet-ct-imaging-features-in-diffuse-large-b-cell-lymphoma/ 2024-10-23T07:59:17+00:00 https://quibim.ai/wp-content/uploads/2023/05/Diseno-sin-titulo-23.png https://quibim.ai/cases/empowering-dipg-and-neuroblastoma-through-advanced-imaging-biomarkers/ 2024-11-14T08:54:31+00:00 https://quibim.ai/wp-content/uploads/2024/11/feature_241123_casestudy_neuroblastoma.png https://quibim.ai/cases/predicting-survival-neurotoxicity-and-response-in-b-cell-lymphoma-patients/ 2024-11-21T09:21:24+00:00 https://quibim.ai/wp-content/uploads/2024/07/240709_Predicting-survival-neurotoxicity-and-response-in-B-Cell-lymphoma-patients-treated-with-CAR-T-therapy-using-an-imaging-features-based-model_small.png https://quibim.ai/cases/ai-for-the-prediction-of-treatment-response-in-lung-cancer-poc/ 2024-11-25T09:53:31+00:00 https://quibim.ai/wp-content/uploads/2022/11/Diseno-sin-titulo-12.png https://quibim.ai/cases/predicting-immunotherapy-outcomes-in-patients-with-advanced-nsclc/ 2024-12-11T08:38:58+00:00 https://quibim.ai/wp-content/uploads/2024/12/Feature_M.png https://quibim.ai/cases/predicting-immunotherapy-response-in-advanced-solid-tumors-using-quantitative-imaging-features-extracted-from-immune-pet-scans/ 2024-12-13T11:23:35+00:00 https://quibim.ai/wp-content/uploads/2024/12/Feature_inmunopet.png https://quibim.ai/cases/post-approval-case-study-identifying-patients-suffering-from-axial-spondyloarthritis/ 2024-12-13T11:25:37+00:00 https://quibim.ai/wp-content/uploads/2022/11/postpaoorval3.jpg https://quibim.ai/cases/informing-patient-stratification-strategies-for-pivotal-immunotherapy-study-of-metastatic-prostate-cancer/ 2024-12-13T11:26:43+00:00 https://quibim.ai/wp-content/uploads/2024/12/feature_lava.png https://quibim.ai/cases/ct-based-clinical-radiomics-model-to-predict-progression-and-drive-clinical-applicability-in-locally-advanced-head-and-neck-cancer/ 2024-12-20T12:52:35+00:00 https://quibim.ai/wp-content/uploads/2023/05/Diseno-sin-titulo-25.jpg https://quibim.ai/cases/developing-a-radiomics-based-tool-for-predicting-pathological-complete-response-pcr-to-neoadjuvant-chemotherapy-in-breast-cancer-a-key-module-of-qp-breast/ 2024-12-23T21:24:48+00:00 https://quibim.ai/wp-content/uploads/2024/12/feature_breast.png https://quibim.ai/cases/prediction-of-metastatic-relapse-in-intermediate-high-risk-localized-prostate-cancer-patients-from-staging-medical-images-and-clinical-variables-providence-study/ 2025-04-01T08:44:29+00:00 https://quibim.ai/wp-content/uploads/2023/02/smallcoverprediction.jpg